Search

everythinglearnresearchcommunity

for

Search:↓

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Artesunate is generally safe for severe malaria, but patients should be monitored for delayed anemia after treatment.

The article suggests using four questions to tell apart necessary medicalization from excessive medicalization, focusing on problem significance, social expectations, medical understanding, and effective resolution.

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

Women experience more side effects and have worse blood pressure control from hypertension treatments than men, despite using different medications.

Balding men had lower bone density, while balding women had higher hip bone density.

Older patients sticking to their prostate medication saw lasting health benefits.

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

The conclusion is that recognizing the difference between gender identity and biological sex is crucial in dermatology to improve patient care and research accuracy.

Hair follicles could be used to noninvasively monitor our body's internal clock and help identify risks for related diseases.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

The study suggests pandemic stress might worsen or trigger hair loss problems.

PAD is common but often missed, needing lifestyle changes and medication for better outcomes.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Women with PCOS are more likely to develop kidney stones, especially those with certain PCOS types.

Topical corticosteroids are the main treatment for Erosive Pustular Dermatosis, but recurrence is common after stopping treatment.

Finasteride's link to health issues like male breast cancer, infertility, and prostate cancer needs more research through placebo-controlled trials to confirm.

Older, obese people with many COVID-19 symptoms are more likely to suffer from severe long-term COVID-19 effects.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Women with PCOS have more severe liver disease.

Hair loss can cause low self-esteem, anxiety, and depression in men.

Radiotherapy was effective for treating a large scalp plaque of Bowen's disease when other treatments failed.

Many patients with Alopecia Areata in Korea experience anxiety, depression, and reduced quality of life, which are often unrelated to the severity of hair loss.

People with alopecia areata often have lower iron levels than healthy people.

Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.

Higher BMI links to worse hair loss in Taiwanese men.

Polycystic Ovary Syndrome (PCOS) symptoms vary globally, with bloating, high cholesterol, and glucose levels being common; the current diagnostic criteria may need refining.

The conclusion is that there's no significant link between male pattern baldness and the severity of coronary artery disease.